Clinical significance of quantitative immunohistology in labial salivary glands for diagnosing Sjögren's syndrome

Rheumatology

Volumn 45, Issue 4, 2006, Pages 470-477

  van Woerkom, J M ^c   Kruize, A A ^c   Barendregt, P J ^a   Kater, L ^c   Hene R ^c   Bootsma, H ^b   Custers, R J H ^c   Jacobs, J W G ^c   Bijlsma, J W J ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Primary Sj gren's syndrome; Quantitative immunohistology; Sicca syndrome

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GOLD STANDARD; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; IMMUNOLOGICAL PARAMETERS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; MEDICAL PARAMETERS; PREDICTION; PRIORITY JOURNAL; SALIVARY GLAND BIOPSY; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME;

AUTOANTIBODIES; BLOOD SEDIMENTATION; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LYMPHOCYTES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RHEUMATOID FACTOR; SALIVARY GLANDS; SENSITIVITY AND SPECIFICITY; SJOGREN'S SYNDROME;

EID: 33645309392     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei191     Document Type: Article

References (21)

1. Kruize AA, Hene RJ, van der Heide A et al. Long-term followup of patients with Sjögren's syndrome. Arthritis Rheum 1996;39:297-303.
2. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 1968;21:656-60.
3. Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 1974;37:217-29.
4. Takeda Y, Komori A. Focal lymphocytic infiltration in the human labial salivary glands: A postmortem study. J Oral Pathol 1986; 15:83-6.
5. Manthorpe R, Benoni C, Jacobsson L et al. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome? Ann Rheum Dis 2000;59:54-60.
6. Zandbelt MM, van den Hoogen FH, de Wilde PC, van den Berg PJ, Schneider HG, van de Putte LB. Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjögren's syndrome. Ann Rheum Dis 2001;60:511-3.
7. Anderson LG, Cummings NA, Asofsky R et al. Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome. Natural history and response to treatment. Am J Med 1972;53:456-63.
8. Talal N, Asofsky R, Lightbody P. Immunoglobulin synthesis by salivary gland lymphoid cells in Sjögren's syndrome. J Clin Invest 1970;49:49-54.
9. Matthews JB, Deacon EM, Wilson C, Potts AJ, Hamburger J. Plasma cell populations in labial salivary glands from patients with and without Sjögren's syndrome. Histopathology 1993; 23:399-407.
10. Speight PM, Cruchley A, Williams DM. Quantification of plasma cells in labial salivary glands: Increased expression of IgM in Sjögren's syndrome. J Oral Pathol Med 1990;19:126-30.
11. de Wilde PC, Kater L, Baak JP, van Houwelingen JC, Hene RJ, Slootweg PJ. A new and highly sensitive immunohistologic diagnostic criterion for Sjögren's syndrome. Arthritis Rheum 1989;32:1214-20.
12. Bodeutsch C, de Wilde PC, Kater L et al. Quantitative immunohistologic criteria are superior to the lymphocytic focus score criterion for the diagnosis of Sjögren's syndrome. Arthritis Rheum 1992; 35:1075-87.
13. Zandbelt MM, Wentink JR, de Wilde PC, van Damme PA, van de Putte LB, van den Hoogen FH. The synergistic value of focus score and IgA% score of sublabial salivary gland biopsy for the accuracy of the diagnosis of Sjögren's syndrome: A 10-year comparison. Rheumatology 2002;41:819-23.
14. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
15. Reichlin M. Clinical significance of anti-Ro/SS-A and anti-La/SS-B antibodies. Up to date online version 13.1. 25 April 2005.
16. Harley JB, Alexander EL, Bias WB et al. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum 1986;29:196-206.
17. Phan TG, Wong RC, Adelstein S. Autoantibodies to extractable nuclear antigens: Making detection and interpretation more meaningful. Clin Diagn Lab Immunol 2002;9:1-7.
18. Peene I, Meheus L, Veys EM, De Keyser F. Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/ or anti-SSB: The range of associated diseases differs according to the detailed serotype. Ann Rheum Dis 2002;61:1090-4.
19. Haneji N, Nakamura T, Takio K et al. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 1997;276:604-7.
20. Nordmark G, Rorsman F, Ronnblom L et al. Autoantibodies to alpha-fodrin in primary Sjögren's syndrome and SLE detected by an in vitro transcription and translation assay. Clin Exp Rheumatol 2003;21:49-56.
21. Zandbelt MM, Vogelzangs J, van de Putte LB, van Venrooij WJ, van den Hoogen FH. Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sjögren's syndrome. Arthritis Res Ther 2004;6:R33-8.